Literature DB >> 15465483

Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.

Susan L Dagenais1, Rebecca L Hartsough, Robert P Erickson, Marlys H Witte, Matthew G Butler, Thomas W Glover.   

Abstract

The molecular events involved in lymphatic development are poorly understood. Hence, the genes responsible for hereditary lymphedema are of great interest due to the potential for providing insights into the mechanisms of lymphatic development, the diagnosis, prevention and treatment of lymphedema, and lymphangiogenesis during tumor growth. Mutations in the FOXC2 transcription factor cause a major form of hereditary lymphedema, the lymphedema-distichiasis syndrome. We have conducted a study of Foxc2 expression during mouse development using immunohistochemistry, and examined its expression in lymphatics compared to its paralog Foxc1 and to Vegfr-3, Prox1 and other lymphatic and blood vascular proteins. We have found that Foxc2 is expressed in lymphatic primordia, jugular lymph sacs, lymphatic collectors and capillaries, as well as in podocytes, developing eyelids and other tissues associated with abnormalities in lymphedema-distichiasis syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465483     DOI: 10.1016/j.modgep.2004.07.004

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  32 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation.

Authors:  Matthew G Butler; Susan L Dagenais; José L Garcia-Perez; Pascal Brouillard; Miikka Vikkula; Peter Strouse; Jeffrey W Innis; Thomas W Glover
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

Review 3.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

4.  Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells.

Authors:  Konstantin I Ivanov; Yan Agalarov; Leena Valmu; Olga Samuilova; Johanna Liebl; Nawal Houhou; Hélène Maby-El Hajjami; Camilla Norrmén; Muriel Jaquet; Naoyuki Miura; Nadine Zangger; Seppo Ylä-Herttuala; Mauro Delorenzi; Tatiana V Petrova
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

5.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.

Authors:  Joseph M Rutkowski; Monica Moya; Jimmy Johannes; Jeremy Goldman; Melody A Swartz
Journal:  Microvasc Res       Date:  2006-07-28       Impact factor: 3.514

6.  Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient mice.

Authors:  Hiroshi Shimoda; Michael J Bernas; Marlys H Witte
Journal:  Histochem Cell Biol       Date:  2011-05-26       Impact factor: 4.304

Review 7.  The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.

Authors:  Noelia Escobedo; Guillermo Oliver
Journal:  Cell Metab       Date:  2017-08-24       Impact factor: 27.287

Review 8.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

Review 9.  Foxc2 transcription factor: a newly described regulator of angiogenesis.

Authors:  Tsutomu Kume
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

10.  Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice.

Authors:  Noelia Escobedo; Steven T Proulx; Sinem Karaman; Miriam E Dillard; Nicole Johnson; Michael Detmar; Guillermo Oliver
Journal:  JCI Insight       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.